Published September, 2017
By Collie Wyatt Conoley, Collie W. Conoley and Michael J. Scheel
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

Goal Focused Positive Psychotherapy (GFPP) is the first comprehensive approach to strength-oriented therapy that fully incorporates positive psychology principles. This book provides instruction for therapists and students wishing to learn a strength-oriented mindset and the necessary skills.

---

Published September, 2017
By Myrna M. Weissman, John C. Markowitz and Gerald L. Klerman
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

The Guide to Interpersonal Psychotherapy is the definitive, practical guide to Interpersonal Psychotherapy (IPT) for clinicians and researchers.

---

Published September, 2017
By Martha H. Verbrugge
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

Active Bodies examines the ideas, programs, and experiences of white and black female physical educators from the introduction of mandatory gym class through the recent revolution in women's sports. Amidst sweeping changes in science, feminism, and attitudes about gender, race, and sexuality, women teachers debated how to achieve equity for their female students and themselves.

---

Published September, 2017
By Matthew D. McEvoy and Cory M. Furse
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

---

Published September, 2017
By Allen Buchanan
Publisher: Oxford University Press (Oxford University Press Inc)
Series: Philosophy in Action
Rating:
Availability: Available

---

Published September, 2017
By Hans Steiner, Michael Kelly, Christina Stadler and Whitney Daniels
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

Disruptive behavior is extremely common. This book discusses state of the art studies of taxonomy, epidemiology, etiology, and treatment, along with forensic implications. Each chapter concludes with a series of clinical cases. Resources are provided for clinicians, researchers, teacher, primary care physicians, criminologists, forensic experts and interested lay people.

---

Published September, 2017
By Katharine A. Phillips and Katharine Phillips
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

This landmark book is the first comprehensive edited volume on body dysmorphic disorder (BDD), a common, severe, and underrecognized disorder. Its contributors are leading researchers and clinicians in the field. This book fills a major gap in the literature by providing clinicians and researchers with cutting-edge, indispensable information on all aspects of BDD and its treatment.

---

Published September, 2017
By Helen V. Firth and Jane A. Hurst
Publisher: Oxford University Press
Series: Oxford Desk Reference Series
Rating:
Availability: Available

The new edition of this classic text provides a practical, easy-to-use guide to clinical consultation in genetics, covering the process of diagnosis, investigation, management, and counselling for patients. All genetic conditions are covered as well as referral categories for a clinical genetic opinion.

---

Published September, 2017
By B. Timothy Walsh, Raquel E. Gur, Edna B. Foa, Dwight L. Evans, Daniel Romer, Martin E.P. Seligman, Herbert Hendin and Charles P. O'Brien
Publisher: Oxford University Press (Oxford University Press Inc)
Series: Adolescent Mental Health Initiative
Rating: 1.00
Availability: Available

This volume reviews the latest information about the treatment and prevention of major mental disorders that emerge during adolescence. It should be a primary resource for both clinicians and researchers, with special attention to gaps in our knowledge.

---

Published September, 2017
By Jessica Flanigan
Publisher: Oxford University Press (Oxford University Press Inc)
Rating:
Availability: Available

Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements.

---